Skip to main content
. 2017 Sep 6;6(10):2203–2212. doi: 10.1002/cam4.1152

Figure 3.

Figure 3

Conditional melanoma‐specific survival according to sex, stage, and age at diagnosis. Each patient's full follow‐up was considered, however, the figures have been truncated at 15 years after diagnosis. (A) 18–45 years at diagnosis and surviving 1 year (n = 25,508 localized, n = 2342 regional, and n = 279 distant); (B) 46–54 years at diagnosis and surviving 1 year (n = 16,970 localized, n = 1679 regional, and n = 265 distant); (C) ≥55 years at diagnosis and surviving 1 year (n = 44,209 localized, n = 5555 regional, and n = 883 distant); (D) 18–45 years at diagnosis and surviving 3 years (n = 22,613 localized, n = 1754 regional, and n = 122 distant); (E) 46–54 years at diagnosis and surviving 3 years (n = 14,491 localized, n = 1188 regional, and n = 124 distant); (F) ≥55 years at diagnosis and surviving 3 years (n = 34,741 localized, n = 3316 regional, and n = 353 distant); (G) 18–45 years at diagnosis and surviving 5 years (n = 19,641 localized, n = 1376 regional, and n = 87 distant); (H) 46–54 years at diagnosis and surviving 5 years (n = 12,131 localized, n = 931 regional, and n = 79 distant); (I) ≥55 years at diagnosis and surviving 5 years (n = 26,625 localized, n = 2301 regional, and n = 200 distant).